Want to see EVH full AI Analyst Report?
Evolent Health (EVH) Ratios
Evolent Health Ratios
EVH's free cash flow for Q2 2026 was $-23.55M. For the 2026 fiscal year, EVH's free cash flow was decreased by $-13.26M and operating cash flow was $-10.30M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 |
| Quick Ratio | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 |
| Cash Ratio | 0.39 | 0.15 | 0.29 | 0.43 | 0.60 |
| Solvency Ratio | -0.28 | 0.04 | 0.01 | 0.07 | 0.03 |
| Operating Cash Flow Ratio | 0.10 | 0.03 | 0.21 | -0.03 | 0.09 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -977.67M | $ -936.03M | $ -928.93M | $ -479.82M | $ -201.87M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.52 | 0.28 | 0.24 | 0.26 | 0.20 |
| Debt-to-Equity Ratio | 2.38 | 0.71 | 0.60 | 0.55 | 0.40 |
| Debt-to-Capital Ratio | 0.70 | 0.42 | 0.38 | 0.36 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.70 | 0.33 | 0.36 | 0.32 | 0.24 |
| Financial Leverage Ratio | 4.57 | 2.54 | 2.51 | 2.11 | 2.05 |
| Debt Service Coverage Ratio | -6.28 | 0.44 | 1.19 | 5.59 | 2.17 |
| Interest Coverage Ratio | -0.08 | -1.64 | -1.31 | 0.23 | -1.67 |
| Debt to Market Cap | 2.12 | 0.51 | 0.16 | 0.16 | 0.09 |
| Interest Debt Per Share | 9.17 | 6.44 | 6.28 | 5.25 | 3.55 |
| Net Debt to EBITDA | -2.32 | 7.18 | -18.24 | 6.58 | 0.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.14% | 14.38% | 23.45% | 23.42% | 27.58% |
| EBIT Margin | -25.43% | -1.50% | -7.55% | -3.44% | -0.48% |
| EBITDA Margin | -19.26% | 3.32% | -1.26% | 3.24% | 6.13% |
| Operating Profit Margin | -0.24% | -1.58% | -3.63% | 0.27% | -4.67% |
| Pretax Profit Margin | -28.50% | -2.47% | -10.31% | -4.59% | -3.28% |
| Net Profit Margin | -28.49% | -2.41% | -5.76% | -1.42% | -4.14% |
| Continuous Operations Profit Margin | -28.49% | -2.41% | -5.76% | -1.38% | -3.34% |
| Net Income Per EBT | 99.98% | 97.76% | 55.85% | 30.87% | 126.17% |
| EBT Per EBIT | 12054.93% | 155.70% | 284.23% | -1704.48% | 70.27% |
| Return on Assets (ROA) | -28.14% | -2.42% | -4.22% | -1.05% | -2.65% |
| Return on Equity (ROE) | -128.74% | -6.15% | -10.59% | -2.23% | -5.42% |
| Return on Capital Employed (ROCE) | -0.29% | -2.21% | -3.55% | 0.26% | -4.35% |
| Return on Invested Capital (ROIC) | -0.29% | -1.95% | -1.97% | 0.08% | -4.32% |
| Return on Tangible Assets | -86.24% | -8.48% | -13.93% | -2.94% | -5.27% |
| Earnings Yield | -117.00% | -4.78% | -3.08% | -0.73% | -1.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.80 | 6.16 | 4.40 | 5.31 | 6.95 |
| Payables Turnover | 26.64 | 22.78 | 31.16 | 18.11 | 6.84 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 22.03 | 32.22 | 21.78 | 9.88 | 6.90 |
| Asset Turnover | 0.99 | 1.00 | 0.73 | 0.74 | 0.64 |
| Working Capital Turnover Ratio | 294.82 | -51.64 | 72.68 | 21.97 | 8.15 |
| Cash Conversion Cycle | 49.21 | 43.22 | 71.32 | 48.60 | -0.83 |
| Days of Sales Outstanding | 62.91 | 59.25 | 83.03 | 68.76 | 52.50 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 13.70 | 16.02 | 11.71 | 20.15 | 53.34 |
| Operating Cycle | 62.91 | 59.25 | 83.03 | 68.76 | 52.50 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.34 | 0.16 | 1.28 | -0.12 | 0.45 |
| Free Cash Flow Per Share | 0.04 | -0.05 | 1.02 | -0.53 | 0.16 |
| Dividend Paid and CapEx Coverage Ratio | 0.86 | 0.42 | 3.00 | -0.30 | 1.47 |
| Capital Expenditure Coverage Ratio | 1.14 | 0.75 | 4.96 | -0.30 | 1.55 |
| Operating Cash Flow Coverage Ratio | 0.04 | 0.03 | 0.22 | -0.02 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.01 | 0.07 | -0.01 | 0.04 |
| Free Cash Flow Yield | 1.04% | -0.47% | 3.10% | -1.90% | 0.58% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.79 | -13.89 | -32.51 | -137.29 | -63.34 |
| Price-to-Sales (P/S) Ratio | 0.24 | 0.51 | 1.87 | 1.95 | 2.62 |
| Price-to-Book (P/B) Ratio | 1.10 | 1.29 | 3.44 | 3.06 | 3.43 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 96.07 | -210.54 | 32.28 | -52.71 | 173.02 |
| Price-to-Operating Cash Flow Ratio | 11.76 | 68.75 | 25.77 | -227.74 | 61.46 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.38 | -0.06 | 3.09 | 0.70 |
| Enterprise Value Multiple | -3.58 | 22.39 | -166.50 | 66.73 | 43.04 |
| Enterprise Value | 1.29B | 1.90B | 4.13B | 2.92B | 2.40B |
| EV to EBITDA | -3.58 | 22.39 | -166.50 | 66.73 | 43.04 |
| EV to Sales | 0.69 | 0.74 | 2.10 | 2.16 | 2.64 |
| EV to Free Cash Flow | 272.28 | -309.99 | 36.25 | -58.48 | 174.05 |
| EV to Operating Cash Flow | 33.33 | 101.23 | 28.94 | -252.66 | 61.83 |
| Tangible Book Value Per Share | -7.57 | -7.12 | -7.20 | -3.27 | -0.14 |
| Shareholders’ Equity Per Share | 3.64 | 8.73 | 9.60 | 9.17 | 8.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.02 | 0.44 | 0.70 | -0.02 |
| Revenue Per Share | 16.43 | 22.28 | 17.65 | 14.43 | 10.55 |
| Net Income Per Share | -4.68 | -0.54 | -1.02 | -0.20 | -0.44 |
| Tax Burden | 1.00 | 0.98 | 0.56 | 0.31 | 1.26 |
| Interest Burden | 1.12 | 1.65 | 1.37 | 1.33 | 6.81 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| SG&A to Revenue | 0.15 | 0.10 | 0.00 | 0.00 | 0.24 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 |
| Income Quality | -0.07 | -0.30 | -1.26 | 0.60 | -1.03 |
Currency in USD